• Zeda

  Led · Series B · Mar 2023

  Zeda provides advanced 3D manufacturing and nanotech solutions, with a focus on metal 3D printing for medical, aerospace, defense, space, and energy applications. The company leverages advanced manufacturing technology to address complex engineering and materials challenges for customers in those sectors. Zeda will use the Series B proceeds to fund a new advanced manufacturing digital foundry in Cincinnati, Ohio and to expand its facilities globally. The company also plans to expand into the Asian market for its medical implant applications. Zeda closed a $52M equity and debt financing as part of this Series B and has raised $68M in total capital to date. The company is led by CEO Shri Shetty and is headquartered in Fremont, CA.

• Tau

  Led · Equity · Feb 2023

  Tau develops carbon-conscious protective coatings for high-performance and standard copper, aluminium and steel wires, positioning itself as an innovative supplier to the automotive industry. Its wire products are designed to meet next-generation electric motor requirements, including superior resistance to partial discharge and operation at 800V and above. The company recently completed validation processes with several automotive OEMs and Tier 1 suppliers across Europe, Asia and North America. Tau is ramping up capacity and preparing industrial-scale carbon-neutral winding wire production in Italy. It aims to begin worldwide deliveries by 2024. The company is led by CEO Francesco Taiariol and has secured external growth capital through a recent Series B round. Tau is a technology and sustainable manufacturing company focused on electrification of transport and decarbonization of energy. It develops high-performance wire combining minimized partial discharge, high filling factors, temperature resistance, and high-voltage and frequency optimization. These features aim to enable global producers of electric motors, cars, buses, trucks and aircraft to double the power output of future traction motors while keeping their size. The company is led by CEO Francesco Taiariol, CTO Piero Degasperi and CDO Daniel Rutz. Tau has operations in Turin, Moscow and Berlin. It closed €10.25m in Series A funding and intends to use the proceeds to expand operations and continue development efforts. Tau develops DryCycle® solvent-free wire-coating technology and LILIT® inline quality-control systems for magnet wire and electrical steel, aiming to reduce VOC emissions, greenhouse gases, energy use and waste. Its core products are high-performance insulated wires for automotive, energy and agricultural applications. The company plans to widen its product range of high-performance wires and scale up industrial production to supply global producers of electric cars, buses, trucks, aircraft and ship vessels from early 2022 onwards. Tau has about 40 employees across offices in Turin, Moscow and Berlin. The funding announced will be used to accelerate new product development and industrial scale-up. Led by co-founders Francesco Taiariol (CEO) and Filippo Veglia (CSO), the company emphasizes a simplified, resource-efficient production process.

• Tau Group

  Led · Series B · Feb 2023

  Tau Group operates in the magnet-wire industry, where it is described as an innovator of new wire technologies. Its core offering revolves around the design and production of high-performance magnetic wires used in electrical and electronic applications. The company focuses on improving wire efficiency and performance, positioning itself as a technology leader within this niche sector. Investor interest has grown steadily, culminating in a recently closed €20 million Series C financing. Although no specific revenue, user, or production figures are disclosed, the scale of the latest round signals confidence in Tau Group’s commercial prospects. The fresh capital will allow the firm to continue advancing its proprietary technologies and pursue further growth initiatives.

• Autonomic Materials

  Participated · Equity · Jun 2022

  Autonomic Materials is a Champaign, IL–based developer of self-healing, high-performance protective coatings that leverage proprietary and patented microencapsulation technology. Its product lineup includes AMP-UP 100 for long-term industrial asset protection and the newly introduced AMP-UP RB, which independent third-party testing validated for concrete reinforcement and corrosion protection. The company positions its coatings as ESG-compatible and sustainable. Led by CEO Dr. Gerald Wilson, Autonomic Materials intends to ramp up development and sales of its sustainable protective coatings. The company completed a $3M financing to support those efforts. Autonomic Materials (AMI) is a Champaign, Illinois–based company that manufactures self-healing polymeric systems. Its technology, derived from research by the Autonomous Materials Systems (AMS) Group at the University of Illinois at Urbana-Champaign, adds protection to high-value structures exposed to environmental stresses. The company provides coating systems such as paints that self-repair when scratched or damaged. AMI was founded in 2005 by Dr. Scott White. It is currently working with more than a dozen potential customers and product specifiers. Those potential customers include major coatings producers and end-users.

• DMC Biotechnologies

  Participated · Series B · Dec 2021

  DMC Biotechnologies makes bio-based chemical intermediates using microbial fermentation, with primary applications in home care and human nutrition. The company highlights a deep pipeline of predictable, scalable, cost-competitive products addressing sustainability challenges across industries including animal nutrition, human nutrition, personal and home care, and a broad range of chemical intermediates. Its proprietary technology simplifies biology and aims to make fermentation more predictable and efficient. DMC is based in Boulder, CO and Durham, NC. The company completed the first close of its Series B fundraising, raising $34M. DMC Biotechnologies develops a fermentation-based platform that uses enhanced microbial strains to produce a broad diversity of bio-based products. The company says its technology reduces biological complexity and accelerates development timelines versus historical approaches. DMC aims to enable low-cost, distributed manufacturing of both existing products and new-to-the-world products that require the precision of biology. Its platform is positioned to lower development cost and speed up bioprocess engineering. Financially, DMC has secured non-dilutive awards exceeding $1.8 million from the National Science Foundation, the U.S. Department of Energy, and the U.S. Department of Agriculture. In July 2019 the company announced the first close of a Series A financing, providing additional capital to advance its platform. DMC Biotechnologies builds a low-cost, fermentation-based manufacturing platform that uses enhanced microbial fermentation to produce a broad diversity of bio-based products. The company has developed technology to reduce biological complexity and speed development by modifying the programming language for microbes, and it is pursuing patent-pending methods to overcome historical barriers in the sector. DMC positions itself as a capital-efficient, multi-product company that aims to improve food nutrition, enable distributed manufacturing, create new biology-enabled materials, and reduce dependence on fossil fuels. Financially, DMC announced a first close of $1.75M in equity financing led by Capricorn Venture Partners and has previously secured non-dilutive awards exceeding $1.2M from the National Science Foundation, the U.S. Department of Energy, and the U.S. Department of Agriculture. The company noted a board appointment of Rob van der Meij, Investment Manager of the Capricorn Sustainable Chemistry Fund. DMC is referenced with locations in Boulder, CO, USA and Leuven, Belgium.

No current team members are available.